SCHEMBL17412697

SCHEMBL17412697

CN(C)c1ccc(-c2csc(N)n2)cc1C(F)(F)F

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPL P40238 4/20 0.66
LTA4H P09960 4/20 0.48
RAB9A P51151 9/20 0.47
ALDH1A1 P00352 8/20 0.47
NPC1 O15118 7/20 0.47
SMN1; SMN2 Q16637 7/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
MAPT P10636 8/20 0.47
KDM4E B2RXH2 3/20 0.47
NFKB1 P19838 2/20 0.47
NFKB2 Q00653 2/20 0.47
RELA Q04206 2/20 0.47
AR P10275 1/20 0.47
GFER P55789 1/20 0.47
ALOX5 P09917 1/20 0.46
NOTUM Q6P988 1/20 0.45
HPGD P15428 2/20 0.43
TP53 P04637 2/20 0.43
ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17400589 0.81 MPL (0.71) MPLLTA4HRAB9AALDH1A1NPC1
SCHEMBL128039 0.80 MPL (1.00) MPLLTA4HRAB9AALDH1A1NPC1
SCHEMBL18724008 0.78 MPL (0.71) MPLLTA4HRAB9AALDH1A1NPC1
SCHEMBL21301005 0.78 MPL (0.71) MPLLTA4HRAB9AALDH1A1NPC1
SCHEMBL474200 0.78 MPL (0.71) MPLLTA4HRAB9AALDH1A1NPC1
SCHEMBL17386626 0.78 ALDH1A1 (0.68) MPLLTA4HRAB9AALDH1A1NPC1
SCHEMBL474197 0.77 MPL (0.78) MPLLTA4HRAB9AALDH1A1NPC1
SCHEMBL474206 0.75 MPL (0.67) MPLLTA4HRAB9AALDH1A1NPC1
SCHEMBL17386614 0.75 ALDH1A1 (0.64) MPLLTA4HRAB9AALDH1A1NPC1
SCHEMBL17412793 0.75 MPL (0.61) MPLLTA4HRAB9AALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9562044-B2 2-acylaminothiazole derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2017-02-07 US disclosed
US-20160002218-A1 2-ACYLAMINOTHIAZOLE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC. (JP) 2016-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160002218-A1 2-ACYLAMINOTHIAZOLE DERIVATIVE OR SALT THEREOF CHRM3, CHRM2, CHRM5 MPL 3292/4885LTA4H 944/4885RAB9A 2669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.